Literature DB >> 20516249

Left ventricular hypertrophy: an overlooked cardiovascular risk factor.

Michael A Bauml1, Donald A Underwood.   

Abstract

Left ventricular hypertrophy (LVH) is common in hypertensive patients, and it increases the risk of myocardial infarction, stroke, and death. Recent evidence indicates it is a modifiable risk factor that is not entirely dependent on blood pressure control. The authors review its pathogenesis, diagnosis, and treatment.

Entities:  

Mesh：

Year:  2010        PMID： 20516249     DOI： 10.3949/ccjm.77a.09158

Source DB:  PubMed          Journal:  Cleve Clin J Med        ISSN： 0891-1150            Impact factor:   2.321


  19 in total

1.  Stress Reduction in the Prevention of Left Ventricular Hypertrophy: A Randomized Controlled Trial of Transcendental Meditation and Health Education in Hypertensive African Americans.

Authors:  Robert H Schneider; Hector F Myers; Komal Marwaha; Maxwell A Rainforth; John W Salerno; Sanford I Nidich; Carolyn Gaylord-King; Charles N Alexander; Keith C Norris
Journal:  Ethn Dis       Date:  2019-10-17       Impact factor: 1.847

Review 2.  The role of autophagy in cardiac hypertrophy.

Authors:  Lanfang Li; Jin Xu; Lu He; Lijun Peng; Qiaoqing Zhong; Linxi Chen; Zhisheng Jiang
Journal:  Acta Biochim Biophys Sin (Shanghai)       Date:  2016-04-15       Impact factor: 3.848

Review 3.  Mechanisms of heart failure in obesity.

Authors:  Imo A Ebong; David C Goff; Carlos J Rodriguez; Haiying Chen; Alain G Bertoni
Journal:  Obes Res Clin Pract       Date:  2014-01-06       Impact factor: 2.288

4.  Concordance of measures of left-ventricular hypertrophy in pediatric hypertension.

Authors:  D Mirchandani; J Bhatia; D Leisman; E N Kwon; R Cooper; N Chorny; R Frank; L Infante; C Sethna
Journal:  Pediatr Cardiol       Date:  2013-11-20       Impact factor: 1.655

5.  Plasma fibroblast growth factor 23 and risk of cardiovascular disease: results from the EPIC-Germany case-cohort study.

Authors:  Romina di Giuseppe; Tilmann Kühn; Frank Hirche; Brian Buijsse; Jutta Dierkes; Andreas Fritsche; Rudolf Kaaks; Heiner Boeing; Gabriele I Stangl; Cornelia Weikert
Journal:  Eur J Epidemiol       Date:  2014-12-21       Impact factor: 8.082

6.  Left ventricular hypertrophy and cardiovascular disease risk prediction and reclassification in blacks and whites: the Atherosclerosis Risk in Communities Study.

Authors:  Tochi M Okwuosa; Elsayed Z Soliman; Faye Lopez; Kim A Williams; Alvaro Alonso; Keith C Ferdinand
Journal:  Am Heart J       Date:  2014-10-16       Impact factor: 4.749

7.  Air Pollution, Cardiovascular Outcomes, and Social Disadvantage: The Multi-ethnic Study of Atherosclerosis.

Authors:  Margaret T Hicken; Sara D Adar; Anjum Hajat; Kiarri N Kershaw; D Phuong Do; R Graham Barr; Joel D Kaufman; Ana V Diez Roux
Journal:  Epidemiology       Date:  2016-01       Impact factor: 4.822

8.  Electrocardiographic Left Ventricular Hypertrophy Among Gambian Diabetes Mellitus Patients.

Authors:  M Jobe; A Kane; J C Jones; S Pessinaba; B C Nkum; S Abdou Ba; O A Nyan
Journal:  Ghana Med J       Date:  2015-03

Review 9.  A meta-analytic evaluation of the diagnostic accuracy of the electrocardiographic Peguero-Lo Presti criterion for left ventricular hypertrophy.

Authors:  Jean Jacques Noubiap; Thomas A Agbaedeng; Ulrich Flore Nyaga; Clovis Nkoke; Ahmadou M Jingi
Journal:  J Clin Hypertens (Greenwich)       Date:  2020-07-01       Impact factor: 3.738

10.  Addressing the relationship between cardiac hypertrophy and ischaemic stroke: an observational study.

Authors:  Chaturaka Rodrigo; Sajitha Weerasinghe; Vijayabala Jeevagan; Senaka Rajapakse; Godwin Constantine
Journal:  Int Arch Med       Date:  2012-12-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.